Skip to Primary Navigation

Canada launches MRO to speed drug and device approvals

A photo of a man's hand holding up a small Canadian flag on a hazy field of black and green.
Photo: Vaughn Ridley/Getty Images

Health Canada introduces a reliance framework to accelerate access to treatments, beginning with pediatric and veterinary drugs.

Health Canada has announced the implementation of a new Ministerial Reliance Order (MRO) designed to help Canadians access safe and effective medicines and medical devices more quickly.

First introduced in May, the order allows Canadian regulators to rely on decisions from trusted foreign authorities to streamline reviews, while maintaining domestic

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience